Newborn screening for fragile X syndrome

JAMA Neurology

Volumn 71, Issue 3, 2014, Pages 355-359

  Tassone, Flora ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

EARLY INTERVENTION; FAMILY COUNSELING; FMR1 GENE; FOLLOW UP; FRAGILE X SYNDROME; GENE; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH PROGRAM; HETEROZYGOSITY; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; MUTATIONAL ANALYSIS; NEWBORN; NEWBORN SCREENING; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; RISK REDUCTION; SOCIAL PSYCHOLOGY; TRINUCLEOTIDE REPEAT;

FRAGILE X SYNDROME; GENETIC TESTING; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING;

EID: 84896752738     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.4808     Document Type: Review

References (18)

1. Martin BS, Huntsman MM. Pathological plasticity in fragile X syndrome. Neural Plast. 2012; 2012: 275630.
2. Bailey DB Jr, Raspa M, Bishop E, Holiday D. No change in the age of diagnosis for fragile X syndrome: findings from a national parent survey. Pediatrics. 2009; 124(2): 527-533.
3. Newborn screening: toward a uniform screening panel and system. Genet Med. 2006; 8(suppl 1): 1S-252S.
4. Hagerman RJ, Hagerman PJ, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research. 3rd ed. Baltimore, MD: Johns Hopkins University Press; 2002.
5. Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol. 2013; 12(8): 786-798.
6. Chen Y, Tassone F, Berman RF, et al. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet. 2010; 19(1): 196-208.
7. Hoffman GE, Le WW, Entezam A, et al. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem. 2012; 60(6): 439-456.
8. Kaplan ES, Cao Z, Hulsizer S, et al. Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model. J Neurochem. 2012; 123(4): 613-621.
9. Cao Z, Hulsizer S, Cui Y, et al. Enhanced asynchronous Ca(2+) oscillations associated with impaired glutamate transport in cortical astrocytes expressing Fmr1 gene premutation expansion. J Biol Chem. 2013; 288(19): 13831-13841.
10. Tassone F, Iong KP, Tong TH, et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012; 4(12): 100.
11. Maenner MJ, Baker MW, Broman KW, et al. FMR1 CGG expansions: prevalence and sex ratios. Am J Med Genet B Neuropsychiatr Genet. 2013; 162B(5): 466-473.
12. Bailey DB, Wheeler A, Hoffend C, et al. Early development and behavior of FMR1 premutation infants identified by newborn screening. Paper presented at: First International Conference on the FMR1 Premutation: Basic Mechanisms and Clinical Involvement; June 26, 2013; Perugia, Italy.
13. Rivera S. Visual motion processing deficits in infants with the fragile X premutation. Paper presented at: First International Conference on the FMR1 Premutation: Basic Mechanisms and Clinical Involvement; June 26, 2013; Perugia, Italy.
14. Christie L, Wotton T, Bennetts B, et al. Maternal attitudes to newborn screening for fragile X syndrome. Am J Med Genet A. 2013; 161A(2): 301-311.
15. Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010; 125(1): e17-e23.
16. Bailey DB Jr, Raspa M, Olmsted M, Holiday DB. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A. 2008; 146A(16): 2060-2069.
17. Gürkan CK, Hagerman RJ. Targeted treatments in autism and fragile X syndrome. Res Autism Spectr Disord. 2012; 6(4): 1311-1320.
18. Indah Winarni T, Chonchaiya W, Adams E, et al. Sertraline may improve language developmental trajectory in young children with fragile X syndrome: a retrospective chart review. Autism Res Treat. 2012; 2012: 104317.